Most Recent
Pharmaceutical companies AstraZeneca and Generic Health have laid down their swords in a long-running patent dispute over AstraZeneca's cholesterol drug Crestor, two-and-a-half years after the High Court of Australia found the patent obvious and invalid.
Publicly traded law firm Shine Lawyers has assured investors it can wage a successful defence against a $250 million class action claiming the firm misled shareholders about the value of ongoing business activities.
A judge ruled Wednesday that online educator TalentMed violated the copyright of educational materials prep company Career Step when it "cut corners" and lifted text to create a competing course.
Reckitt Benckiser has been ordered to pay all of GlaxoSmithKline's legal bill after a judge found the drug giant misled consumers with claims that Nurofen was a more effective pain killer than its rival's Panadol.
The Australian Competition and Consumer Commission said it is well positioned to investigate competition in the financial sector, in response to a recent report calling for a dedicated financial services competition regulator.
The class actions against car companies over defective Takata airbags are expected to dramatically grow after the first-of-its-kind mandatory recall announced by the government Wednesday.
Alcohol, anti-depressants and the common use of bad language at the Illawarra coal mine did not excuse a sacked miner's threatening and expletive-laced phone calls to colleagues, the full Fair Work Commission has found.
Qantas Ground Services has lost its challenge to the Full Fair Work Commission in a dispute with the Transport Workers Union over the classification of the company's commissionaires, a small group of employees who transport disabled and elderly passengers between terminals.
The Australian Competition and Consumer Commission will review the proposed $2 billion acquisition of Sydney's WestConnex toll road by the Sydney Transport Partners Consortium for potential competition concerns.
Auditing firm Pitcher Partners has filed its defence in a class action accusing it of wrongly signing off on Slater & Gordon's financial reports, denying responsibility for alleged material misstatements that investors say they relied on to their detriment.